RxDoctor Payments Data

Mary Polan

Obstetrics & Gynecology · New York, NYNPI 1336164623

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.9%), ownership interests and other — rather than concentrated in one kind of arrangement. 3 manufacturers reported payments, led by Ortho-clinical Diagnostics, Inc. at 57.1% of the total. Among obstetrics & gynecology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$862,345in general payments, 2019–2025

Across 27 payments — averaging $31,939 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ortho-clinical Diagnostics, Inc.$492K
  • Quidel Corporation$317K
  • Pfizer$53K

What the payments were for

  • Consulting fees$473,57155%
  • Travel & lodging$26,9943%
  • Food & beverage$1,4860%
  • Ownership interest$307,65936%
  • Other$52,6356%

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Ortho-clinical Diagnostics, Inc.11$492,250
Quidel Corporation15$317,460
Pfizer1$52,635

How this compares

$862,345 in reported general payments places this provider in the 95th percentile of 2,673 obstetrics & gynecology providers in New York.

See all obstetrics & gynecology providers in New York

Other obstetrics & gynecology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →